Growth Metrics

Icu Medical (ICUI) Cash & Equivalents (2016 - 2025)

Icu Medical's Cash & Equivalents history spans 17 years, with the latest figure at $308.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents changed 0.2% year-over-year to $308.0 million, compared with a TTM value of $308.0 million through Dec 2025, changed 0.2%, and an annual FY2025 reading of $308.0 million, changed 0.2% over the prior year.
  • Cash & Equivalents for Q4 2025 was $308.0 million at Icu Medical, up from $299.7 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $552.8 million in Q4 2021, with the low at $195.9 million in Q2 2023.
  • Average Cash & Equivalents over 5 years is $311.9 million, with a median of $299.9 million recorded in 2025.
  • Year-over-year, Cash & Equivalents crashed 62.23% in 2022 and then surged 58.48% in 2024.
  • Tracing ICUI's Cash & Equivalents over 5 years: stood at $552.8 million in 2021, then crashed by 62.23% to $208.8 million in 2022, then increased by 21.76% to $254.2 million in 2023, then grew by 21.38% to $308.6 million in 2024, then decreased by 0.2% to $308.0 million in 2025.
  • Per Business Quant, the three most recent readings for ICUI's Cash & Equivalents are $308.0 million (Q4 2025), $299.7 million (Q3 2025), and $300.0 million (Q2 2025).